The Sherlock™ CRISPR-based SARS-CoV-2 kit was the very first FDA authorized CRISPR-based EUA diagnostic test for use in clinical laboratory settings
The Sherlock™ CRISPR-based SARS-CoV-2 kit is intended for the qualitative detection of nucleic acid from SARS-CoV-2. This test provides specific and sensitive detection of the SARS-CoV-2 virus in upper respiratory tract and bronchoalveolar lavage specimens from individuals suspected of COVID-19 by their healthcare provider.